Skip to content
★ Sign in to follow
PT
Total declarations
13
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 20 Jul 2023 for GSK plc, €5,384.

Filing timeline

BuySale
P Thomson

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

Closed purchases

Market purchases
4

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

  • GSK plc 4 purchases · last 20 Jul 2023

P Thomson: trading record in brief

All filings by P Thomson on record concern GSK plc. We count 13 filings; the first trade dates from 9 August 2022 and the latest from 18 July 2023.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The newest entry dates from 20 July 2023: a share grant of €5,384, in GSK plc. Between a trade and the moment it shows up on RNS (LSE), the median delay is 2 days. For comparison, UK MAR gives managers three business days to notify a trade. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.

Companies and markets linked to P Thomson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ◆
    President, Global AffairsExecutivesGSK plc
    4,628 GBP30RNS
    348 shares@ £13.3080.9% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4842360-9
  • ▲
    President, Global AffairsExecutivesGSK plc
    0RNS
    0London Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4842360-21
    Canonical exit: 16 Oct 2023 (T+90)
  • ▲
    President, Global AffairsExecutivesGSK plc
    574 GBP41RNS
    43 shares@ £13.35310.1% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4837969-8
    Canonical exit: 11 Oct 2023 (T+90)
  • ▲
    President, Global AffairsExecutivesGSK plc
    261 GBP40RNS
    20 shares@ £13.0674.6% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4835002-6
    Canonical exit: 9 Oct 2023 (T+90)
  • ▲
    President, Global AffairsExecutivesGSK plc
    248 GBP40RNS
    18 shares@ £13.79674.3% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4799763-6
    Canonical exit: 7 Sept 2023 (T+90)

5 of 5 declarations